These include: Pregnant or breastfeeding women Individuals with severe kidney disease People with asthma or severe allergies Patients taking certain medications that may interact with antioxidants Consulting a doctor before starting treatment is always recommended
Here is what a competent provider evaluation includes before recommending either peptide: Baseline hormone panel including IGF-1, testosterone, thyroid, and cortisol Fasting blood glucose and metabolic markers (GH peptides can affect insulin sensitivity) Review of current medications and supplements for interactions Assessment of sleep quality, energy, recovery rate, and body composition trends Discussion of treatment goals and realistic expectations A protocol with defined monitoring checkpoints not a static dose-and-forget plan BPC-157, Ipamorelin, and CJC-1295 are sometimes self-sourced from unregulated online suppliers
One hypothesis is that GHRP-6 and GHRP-2 have off-target activity at corticotroph cells or hypothalamic CRH neurons that ipamorelin lacks due to its modified structure
Luo D, Geng J, Li N, Carter KA, Shao S, Atilla-Gokcumen GE, et al
Evidencia cientfica La evidencia preclnica sita a IGF-1 LR3 dentro del eje somatotrpico GH/IGF-1, en el que la hormona de crecimiento induce la produccin heptica de IGF-1, mediador de muchos de sus efectos anablicos